相关实验视频

Updated: Jul 13, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

在SARS-CoV-2药物发现的社区努力

Johannes Schimunek, Philipp Seidl, Katarina Elez

Molecular informatics

|October 13, 2023

概括

一项开放科学挑战选了数十亿个分子,以找到针对COVID-19的小分子药物. 研究人员确定了27种具有弱抑制性的化合物,有助于未来对SARS-CoV-2的药物发现.

科学领域:

药物发现药物发现药物发现
计算化学计算化学
病毒学病毒学

背景情况:

由于COVID-19的流行,需要持续开发可访问的小分子疗法.
仅靠疫苗是不够的,这凸显了需要多样化的治疗选择,特别是在资源有限的环境中.

研究的目的:

使用开放科学,众包计算查方法,识别针对SARS-CoV-2标的新型小分子抑制剂.
为了利用大规模的虚拟查努力,涉及到一个全球社区,以加速药物发现.

主要方法:

这是一个很棒的节目,这是一个很棒的节目.
十亿个分子对抗COVID-19的挑战
涉及31个团队,通过计算选超过10亿个虚拟分子对抗6个关键的SARS-CoV-2蛋白质标.
达成共识的排名确定了有前途的化合物,随后对878个选定分子进行了实验合成和生物测试.
试验包括结合,裂解抑制和病毒抑制,以评估化合物的疗效.

主要成果:

27种化合物表现出对SARS-CoV-2标的弱抑制或结合,包括蛋白酶,核囊蛋白和尖端蛋白.
该研究确定了潜在的化合物,以进一步优化COVID-19药物发现.
这次大规模的合作努力展示了开放科学在应对全球卫生挑战方面的力量.

结论:

开放科学倡议可以为识别COVID-19等病毒性疾病的潜在治疗剂做出重大贡献.
这些已识别的化合物为开发更强大,更易于获得的SARS-CoV-2治疗提供了起点.
这种方法增强了未来传染病药物发现工作的集体知识基础.

关键词:

在 COVID-19 疫情中,这就是SARS-CoV-2病毒.发现药物的发现.机器学习是机器学习.

更多相关视频

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Published on: April 9, 2021

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...